Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in California
| Provider | Medicare | Services |
|---|---|---|
| Esoterix, Inc | $21.73 | 366 |
| Unilab Corporation | $21.73 | 158 |
| Prometheus Laboratories Inc. | $21.73 | 144 |
| Laboratory Corporation Of America | $21.73 | 82 |
| Unilab Corporation | $21.73 | 68 |
| Specialty Laboratories Inc | $21.73 | 47 |
| Quest Diagnostics Nichols Institute | $21.73 | 41 |
| Regents Of The University Of | $21.73 | 19 |
California Pricing in Context
In California, CPT code 84433 (Evaluation Of Thiopurine S-Methyltransferase (tpmt)) carries an average Medicare payment of $21.73 — 0% above the national benchmark of $21.71. 10 providers across the state submitted claims for this procedure in 2023, performing 931 total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in California is $416.60, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Urinalysis procedures, the estimated commercial insurance price in California lands near $52.15, with self-pay cash prices typically around $130.86. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Evaluation Of Thiopurine S-Methyltransferase (tpmt) cost in California?
The average Medicare payment for Evaluation Of Thiopurine S-Methyltransferase (tpmt) in California is $21.73, which is 0% above the national average of $21.71. Providers in CA typically bill $416.60 for this procedure.
What does Evaluation Of Thiopurine S-Methyltransferase (tpmt) cost with insurance in California?
With commercial insurance in California, Evaluation Of Thiopurine S-Methyltransferase (tpmt) costs an estimated $52.15. Without insurance, the estimated cash price is $130.86. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Evaluation Of Thiopurine S-Methyltransferase (tpmt) in California?
10 providers in California billed Medicare for Evaluation Of Thiopurine S-Methyltransferase (tpmt) in 2023, performing 931 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Evaluation Of Thiopurine S-Methyltransferase (tpmt) cheaper in California than the national average?
No — Evaluation Of Thiopurine S-Methyltransferase (tpmt) costs 0% above the national average in California. The state average Medicare payment is $21.73 compared to $21.71 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.